BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31841875)

  • 1. Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
    Lester E; DiStefano S; Mace R; Macklin E; Plotkin S; Vranceanu AM
    Gen Hosp Psychiatry; 2020; 62():72-78. PubMed ID: 31841875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
    Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
    Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
    Lester EG; Gates MV; Vranceanu AM
    Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
    Lester EG; Macklin EA; Plotkin S; Vranceanu AM
    J Neurooncol; 2020 Apr; 147(2):451-457. PubMed ID: 32078086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
    Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
    JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
    Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
    J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
    Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
    JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
    Reichman M; Riklin E; Macklin E; Vranceanu AM
    Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
    Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
    J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention.
    Funes CJ; Zale EL; Luberto CM; Vranceanu AM
    Complement Ther Med; 2019 Feb; 42():114-118. PubMed ID: 30670227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
    Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
    JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resilient youth with neurofibromatosis: Less perceived stress and greater life satisfaction after an 8-week virtual mind-body intervention.
    Lester E; Vranceanu AM
    J Psychosoc Oncol; 2021; 39(5):680-685. PubMed ID: 33191871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.
    Kanaya MR; Greenberg J; Bakhshaie J; Vranceanu AM
    J Neurooncol; 2024 Apr; 167(2):315-322. PubMed ID: 38409461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.
    Greenberg J; Carter S; Lester E; Funes CJ; Macklin EA; Plotkin S; Vranceanu AM
    J Neurooncol; 2019 Dec; 145(3):561-569. PubMed ID: 31677033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
    Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
    J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
    Wei G; Farooq J; Kumar A
    Dermatol Ther; 2021 Jan; 34(1):e14613. PubMed ID: 33258517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
    Vranceanu AM; Merker VL; Plotkin SR; Park ER
    J Neurooncol; 2014 Oct; 120(1):103-9. PubMed ID: 25022450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Virtual Resiliency Intervention Promoting Resiliency for Parents of Children with Learning and Attentional Disabilities: A Randomized Pilot Trial.
    Park ER; Perez GK; Millstein RA; Luberto CM; Traeger L; Proszynski J; Chad-Friedman E; Kuhlthau KA
    Matern Child Health J; 2020 Jan; 24(1):39-53. PubMed ID: 31650412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can a Dyadic Resiliency Program Improve Quality of Life in Cognitively Intact Dyads of Neuro-ICU Survivors and Informal Caregivers? Results from a Pilot RCT.
    Lester EG; Mace RA; Bannon SM; Popok PJ; Gates MV; Meyers E; Tehan T; Sagueiro D; Rosand J; Macklin EA; Vranceanu AM
    Neurocrit Care; 2021 Dec; 35(3):756-766. PubMed ID: 33880701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
    Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
    J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.